| CD58; CD58 molecule [KO: K06492] |
| |
| CD80; CD80 molecule [KO: K05412] |
| CD274; CD274 molecule [KO: K06745] |
| CD28; CD28 molecule [KO: K06470] |
| CD86; CD86 molecule [KO: K05413] |
| CTLA4; cytotoxic T-lymphocyte-associated protein 4 [KO: K06538] |
| ICOSLG; inducible T-cell co-stimulator ligand [KO: K06710] |
| ICOS; inducible T-cell co-stimulator [KO: K06713] |
| BOLA-DMA; major histocompatibility complex, class II, DM alpha [KO: K06752] |
| BOLA-DMB; major histocompatibility complex, class II, DM beta [KO: K06752] |
| BOLA-DOB; major histocompatibility complex, class II, DO beta [KO: K06752] |
| BOLA-DQA5; major histocompatibility complex, class II, DQ alpha 5 [KO: K06752] |
| BOLA-DQB; major histocompatibility complex, class II, DQ beta [KO: K06752] |
| BOLA-DYB; major histocompatibility complex, class II, DY beta [KO: K06752] |
| BOLA-DQA1; major histocompatibility complex, class II, DQ alpha, type 1 [KO: K06752] |
| BOLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO: K06752] |
| BOLA-DRB3; major histocompatibility complex, class II, DRB3 [KO: K06752] |
| BOLA-DOA; major histocompatibility complex, class II, DO alpha [KO: K06752] |
| BOLA-DRA; major histocompatibility complex, class II, DR alpha [KO: K06752] |
| BLA-DQB; MHC class II antigen [KO: K06752] |
| LA-DQB; MHC cell surface glycoprotein [KO: K06752] |
| SLA class II histocompatibility antigen; K06752 major histocompatibility complex, class II [KO: K06752] |
| uncharacterized LOC100296598; K10784 T cell receptor alpha chain V region [KO: K10784] |
| uncharacterized LOC785283; K10784 T cell receptor alpha chain V region [KO: K10784] |
| uncharacterized LOC509513; K10785 T-cell receptor beta chain V region [KO: K10785] |
| T-cell receptor beta chain T17T-22-like; K10785 T-cell receptor beta chain V region [KO: K10785] |
| T-cell receptor beta chain T17T-22-like; K10785 T-cell receptor beta chain V region [KO: K10785] |
| T-cell receptor beta chain T17T-22-like; K10785 T-cell receptor beta chain V region [KO: K10785] |
| T-cell receptor beta chain T17T-22-like; K10785 T-cell receptor beta chain V region [KO: K10785] |
| uncharacterized LOC100336183; K10785 T-cell receptor beta chain V region [KO: K10785] |
| immunoglobulin iota chain-like; K10785 T-cell receptor beta chain V region [KO: K10785] |
| |
| JSP.1; MHC Class I JSP.1 [KO: K06751] |
| major histocompatibility complex; K06751 major histocompatibility complex, class I [KO: K06751] |
| BOLA-N; MHC class I antigen [KO: K06751] |
| BOLA; MHC class I heavy chain [KO: K06751] |
| BOLA-A; major histocompatibility complex, class I, A [KO: K06751] |
| BOLA; MHC class I heavy chain [KO: K06751] |
| class I histocompatibility antigen; K06751 major histocompatibility complex, class I [KO: K06751] |
| uncharacterized protein MGC126945; K06751 major histocompatibility complex, class I [KO: K06751] |
| CD8A; CD8a molecule [KO: K06458] |
| CD8B; CD8b molecule [KO: K06459] |
| PDCD1LG2; programmed cell death 1 ligand 2 [KO: K06708] |
| CD276; CD276 molecule [KO: K06746] |
| VTCN1; V-set domain containing T cell activation inhibitor 1 [KO: K06747] |
| PDCD1; programmed cell death 1 [KO: K06744] |
| CD40; CD40 molecule, TNF receptor superfamily member 5 [KO: K03160] |
| CD40LG; CD40 ligand [KO: K03161] |
| ALCAM; activated leukocyte cell adhesion molecule [KO: K06547] |
| |
| PVR; poliovirus receptor [KO: K06539] |
| CD226; CD226 molecule [KO: K06567] |
| PVRL2; poliovirus receptor-related 2 (herpesvirus entry mediator B) [KO: K06531] |
| TIGIT; T cell immunoreceptor with Ig and ITIM domains [KO: K16350] |
| ITGAL; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1 [KO: K05718] |
| ITGB2; integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) [KO: K06464] |
| ICAM1; intercellular adhesion molecule 1 [KO: K06490] |
| intercellular adhesion molecule 2-like; K06523 intercellular adhesion molecule 2 [KO: K06523] |
| intercellular adhesion molecule 2-like; K06523 intercellular adhesion molecule 2 [KO: K06523] |
| ICAM3; intercellular adhesion molecule 3 [KO: K06486] |
| CD22; CD22 molecule [KO: K06467] |
| PTPRC; protein tyrosine phosphatase, receptor type, C [KO: K06478] [EC: 3.1.3.48] |
| SIGLEC1; sialic acid binding Ig-like lectin 1, sialoadhesin [KO: K06548] |
| |
| PVRL3; poliovirus receptor-related 3-like [KO: K06592] |
| |
| |
| |
| |
| CLDN18; claudin 18 [KO: K06087] |
| CLDN16; claudin 16 [KO: K06087] |
| CLDN11; claudin 11 [KO: K06087] |
| CLDN17; claudin 17 [KO: K06087] |
| |
| CLDN19; claudin 19 [KO: K06087] |
| |
| CLDN14; claudin 14 [KO: K06087] |
| |
| CLDN23; claudin 23 [KO: K06087] |
| CLDN15; claudin 15 [KO: K06087] |
| |
| CLDN10; claudin 10 [KO: K06087] |
| CLDN22; claudin 22 [KO: K06087] |
| |
| CLDN25; claudin 25 [KO: K06087] |
| CLDN24; claudin 24 [KO: K06087] |
| |
| F11R; F11 receptor [KO: K06089] |
| JAM2; junctional adhesion molecule 2 [KO: K06735] |
| JAM3; junctional adhesion molecule 3 [KO: K06785] |
| ESAM; endothelial cell adhesion molecule [KO: K06787] |
| CDH5; cadherin 5, type 2 (vascular endothelium) [KO: K06533] |
| PECAM1; platelet/endothelial cell adhesion molecule [KO: K06471] |
| CD99; CD99 molecule [KO: K06520] |
| ITGAM; integrin, alpha M (complement component 3 receptor 3 subunit) [KO: K06461] |
| SELPLG; selectin P ligand [KO: K06544] |
| SELP; selectin P (granule membrane protein 140kDa, antigen CD62) [KO: K06496] |
| ITGA4; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) [KO: K06483] |
| ITGB1; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) [KO: K05719] |
| ITGA9; integrin, alpha 9 [KO: K06585] |
| VCAM1; vascular cell adhesion molecule 1 [KO: K06527] |
| VCAM1; vascular cell adhesion molecule 1 [KO: K06527] |
| ITGB7; integrin, beta 7 [KO: K06590] |
| MADCAM1; mucosal vascular addressin cell adhesion molecule 1 [KO: K06779] |
| MADCAM1; mucosal vascular addressin cell adhesion molecule 1-like [KO: K06779] |
| |
| GLYCAM1; glycosylation-dependent cell adhesion molecule 1 [KO: K06815] |
| CD34; CD34 molecule [KO: K06474] |
| GLG1; golgi glycoprotein 1 [KO: K06816] |
| |
| PVRL1; poliovirus receptor-related 1 (herpesvirus entry mediator C) [KO: K06081] |
| CDH2; cadherin 2, type 1, N-cadherin (neuronal) [KO: K06736] |
| NCAM1; neural cell adhesion molecule 1 [KO: K06491] |
| NCAM2; neural cell adhesion molecule 2 [KO: K06491] |
| L1CAM; L1 cell adhesion molecule [KO: K06550] |
| CADM1; cell adhesion molecule 1 [KO: K06781] |
| NEGR1; neuronal growth regulator 1 [KO: K06775] |
| |
| LRRC4C; leucine rich repeat containing 4C [KO: K07523] |
| |
| LRRC4; leucine rich repeat containing 4 [KO: K16351] |
| PTPRF; protein tyrosine phosphatase, receptor type, F [KO: K05695] [EC: 3.1.3.48] |
| LRRC4B; leucine rich repeat containing 4B [KO: K16360] |
| |
| |
| |
| |
| ITGAV; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) [KO: K06487] |
| ITGB8; integrin, beta 8 [KO: K06591] |
| ITGA8; integrin, alpha 8 [KO: K06584] |
| |
| |
| |
| NLGN3; neuroligin 3 [KO: K07378] |
| NLGN2; neuroligin 2 [KO: K07378] |
| NLGN1; neuroligin 1 [KO: K07378] |
| NLGN4Y; neuroligin 4, Y-linked-like [KO: K07378] |
| CADM3; cell adhesion molecule 3 [KO: K06780] |
| NRCAM; neuronal cell adhesion molecule [KO: K06756] |
| CNTN1; contactin 1 [KO: K06759] |
| PTPRM; protein tyrosine phosphatase, receptor type, M [KO: K05693] [EC: 3.1.3.48] |
| contactin-2-like; K06760 contactin 2 [KO: K06760] |
| NFASC; neurofascin [KO: K06757] |
| CNTNAP1; contactin associated protein 1 [KO: K07379] |
| CNTNAP2; contactin associated protein-like 2 [KO: K07380] |
| MPZL1; myelin protein zero-like 1 [KO: K06770] |
| MPZ; myelin protein zero [KO: K06770] |
| MAG; myelin associated glycoprotein [KO: K06771] |
| CDH1; cadherin 1, type 1, E-cadherin (epithelial) [KO: K05689] |
| |
| ITGA6; integrin, alpha 6 [KO: K06485] |
| CDH3; cadherin 3, type 1, P-cadherin (placental) [KO: K06796] |
| CDH4; cadherin 4, type 1, R-cadherin (retinal) [KO: K06797] |
| CDH15; cadherin 15, type 1, M-cadherin (myotubule) [KO: K06809] |
| |